Breaking News
0

Mylan Inc (MYL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mylan's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.55 -0.11    -0.28%
21/05 - Closed. Currency in USD ( Disclaimer )
After Hours
39.55
0.00
0.00%
18:31:36 - Real-time Data
Type: Equity
Market: United States
ISIN: NL0011031208 
CUSIP: 001103120
  • Volume: 2,594,543
  • Bid/Ask: 39.34 / 40.04
  • Day's Range: 39.34 - 40.13
Mylan 39.55 -0.11 -0.28%

MYL Overview

 
Information about the Mylan Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close39.66
Day's Range39.34 - 40.13
Revenue14.59B
Open39.82
52 wk Range29.39 - 47.82
EPS1.58
Volume2,594,543
Market Cap20.66B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)5,607,007
P/E Ratio25.07
Beta1.35
1-Year Change4.24%
Shares Outstanding515,445,063
Next Earnings DateAug 07, 2018
What is your sentiment on Mylan?
or
Market is currently closed. Voting is open during market hours.

Mylan Inc News


Should You Give Einhorn The Green Light?
Should You Give Einhorn The Green Light?
By Seeking Alpha - 14 hours ago

GLRE is a reinsurance company whose investment portfolio is managed by hedge fund manager David Einhorn (DME advisors). The bull run in U.S. stocks has led to t

Will 'Public Shaming' Sink Celgene?
Will 'Public Shaming' Sink Celgene?
By Seeking Alpha - 22 hours ago

The FDA posted a list of companies who have been targets of complaints by generic drug makers. CELG topped the list. CELG's public shaming may not lower the pri

Valeant: Much Ado About Nothing
Valeant: Much Ado About Nothing
By Seeking Alpha - May 21, 2018

VRX's Q1 revenue was off 5% Y/Y. Traction within Xifaxan could be encouraging for bulls, however. LOE has not materialized like I had expected. VRX remains high

Mylan Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Neutral Buy Buy
Technical Indicators BUY Strong Sell Sell Strong Buy Neutral
Summary Neutral Strong Sell Neutral Strong Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 5H Current
Harami Bullish 1M Current
Completed Patterns
Abandoned Baby Bearish 1M 3 Feb 18
Evening Doji Star 1M 3 Feb 18
Doji Star Bearish 1M 4 Jan 18

Mylan Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 39.55 39.34 40.04 2,594,543 -0.28% USD 21/05  
  Berlin 34.000 33.600 33.800 0 +0.59% EUR 02:08:00  
  Stuttgart 33.800 0.000 0.000 0 +0.00% EUR 18/05  
  Munich 33.800 0.000 0.000 0 +0.00% EUR 18/05  
  Vienna 34.205 0.000 0.000 0 0.00% EUR 15/12  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  SBI 243.65 244.10 241.60 -0.80 -0.33% 4.44M 00:32:55  
  Tata Motors 300.20 301.95 296.55 +4.30 +1.45% 2.54M 00:32:32  
  Ashok Leyland 137.25 138.55 132.15 +2.95 +2.20% 10.44M 00:32:53  
  DLF 188.75 195.00 183.25 -4.80 -2.48% 6.90M 00:32:56  
  Just Dial 435.75 443.65 415.55 +28.65 +7.04% 3.85M 00:32:37  
  Bajaj Finance 2,166.00 2,167.15 2,110.00 +60.55 +2.88% 518.73K 00:32:49  
  ICICI Bank 292.95 293.85 286.85 +3.65 +1.26% 3.14M 00:32:32  
  Tata Steel Ltd 579.50 581.70 569.50 +2.50 +0.43% 1.70M 00:32:52  
  Yes Bank 338.30 340.75 331.00 +4.15 +1.24% 2.75M 00:32:56  
  Tata Consultancy 3,529.00 3,574.95 3,528.00 -27.75 -0.78% 166.03K 00:32:39  

Mylan Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

35000

Equity Type

ORD

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MYL Comments

Write your thoughts about Mylan Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
João Félix
João Félix Sep 29, 2017 7:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mylan shareholders vote against executive pay. .Directors face strong opposition. .These group of Directors don't have the profile and competency to manage Mylan at this moment in time. That is the main problem of this company.
Reply
1 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email